摘要
用东菱精纯克栓酶（DF-521）对116例急性脑梗塞进行了前瞻性、随机、开放对照治疗研究。并设对照组（常规治疗方法）108例。结果显示：克检酶治疗组总有效率为9741％，疗效明显优于对照组73．15％，并且有作用快，病程短，功能恢复好，不良反应少的优点，是治疗脑梗塞值得推广的药物。
One handread and sixteen patients diagnosed as acute brain infaction were treated by Tobish Batroxobix (DF-521 ). 108 controls were treated routinely. The results showed that the effecti ve rate of DF-521 was 97. 41% which was obviousiy higher than the rate 73- 15% in controls. The advantages of DF-521 are as follows: quicker function, better recovery, shorter course of disease and less harmful responses. So, it should be popularizednow.
出处
《西安医科大学学报》
CSCD
1997年第4期488-491,共4页
Journal of Xi'an Medical University(Chinese)
